Stockholm , Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Redeye Pre-ASCO Seminar in Stockholm. The presentation will take place at 9.15am on Tuesday, May 28, 2019. Dr. Uli Hacksell, CEO of Medivir, will present the latest development and the company´s future.
The presentation will be available via Medivirs website; www.medivir.com.
For further information, please contact:
Uli Hacksell, CEO, Medivir AB, mobile: +46 (0)73 125 0615.
Medivir develops innovative drugs with a focus on cancer where the unmet medical needs